A
$ Value
$0
Shares
20,000
Price
$0
Filed
Apr 2
Insider
Name
Bellon Christine
Title
Chief Legal Officer
CIK
0001963878
Roles
Officer
Transaction Details
Transaction Date
2026-03-31
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
115,667
Footnotes
Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.
Filing Info
Bellon Christine's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | BEAM | ▼ | $146K |
| 2026-03-31 | BEAM | A | $0 |
| 2025-10-01 | BEAM | ▼ | $9K |
Other Insiders at BEAM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Evans John M.
CEO
|
— | $1.9M | 2026-04-01 |
|
Ciaramella Giuseppe
President
|
— | $290K | 2026-04-01 |
|
Emany Sravan Kumar
Chief Financial Officer
|
— | — | 2026-03-31 |
|
Bellon Christine
Chief Legal Officer
|
— | $146K | 2026-04-01 |
|
Simon Amy
Chief Medical Officer
|
— | $165K | 2026-04-01 |
|
Cavanagh Bethany J
SVP, Finance and Treasurer
|
— | $80K | 2026-04-01 |